Carregant...
Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
PURPOSE: A proportion of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) do not achieve treatment goals or experience side effects on their current therapy. In such cases, switching patients to a new drug while discontinuing the first may...
Guardat en:
| Publicat a: | Lung |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942346/ https://ncbi.nlm.nih.gov/pubmed/29470642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-018-0100-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|